http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 05 Oct 2026 08:01:45 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Cannara+raises+Curaleaf+supply+deal+value+to+C%2434+million/27145977.html <p>Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF) has amended its international supply agreement with Curaleaf International Limited, raising the potential aggregate contract value to approximately C$34 million over two years, up from C$21 million under the original agreement announced July 14, 2026.</p> <p>The amended deal is based on committed supply volumes and the terms and conditions of the agreement. Cannabis flower supplied under the agreement will be dried and processed under EU-GMP conditions at Curaleaf's EU-GMP certified facility in Canada before distribution into international medical markets.</p> <p>Cannara's Chief Operating Officer Niko Sosiak noted that 15 of the company's 24 grow rooms at http://www.streetinsider.com/Corporate+News/Cannara+raises+Curaleaf+supply+deal+value+to+C%2434+million/27145977.html Mon, 05 Oct 2026 08:01:45 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Corporate+News/Cannara+raises+Curaleaf+supply+deal+value+to+C%2434+million/27145977.html <p>Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF) has amended its international supply agreement with Curaleaf International Limited, raising the potential aggregate contract value to approximately C$34 million over two years, up from C$21 million under the original agreement announced July 14, 2026.</p> <p>The amended deal is based on committed supply volumes and the terms and conditions of the agreement. Cannabis flower supplied under the agreement will be dried and processed under EU-GMP conditions at Curaleaf's EU-GMP certified facility in Canada before distribution into international medical markets.</p> <p>Cannara's Chief Operating Officer Niko Sosiak noted that 15 of the company's 24 grow rooms at http://www.streetinsider.com/Corporate+News/Cannara+raises+Curaleaf+supply+deal+value+to+C%2434+million/27145977.html Mon, 05 Oct 2026 08:01:45 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Corporate+News/Cannara+raises+Curaleaf+supply+deal+value+to+C%2434+million/27145977.html <p>Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF) has amended its international supply agreement with Curaleaf International Limited, raising the potential aggregate contract value to approximately C$34 million over two years, up from C$21 million under the original agreement announced July 14, 2026.</p> <p>The amended deal is based on committed supply volumes and the terms and conditions of the agreement. Cannabis flower supplied under the agreement will be dried and processed under EU-GMP conditions at Curaleaf's EU-GMP certified facility in Canada before distribution into international medical markets.</p> <p>Cannara's Chief Operating Officer Niko Sosiak noted that 15 of the company's 24 grow rooms at http://www.streetinsider.com/Corporate+News/Cannara+raises+Curaleaf+supply+deal+value+to+C%2434+million/27145977.html Mon, 05 Oct 2026 08:01:45 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Corporate+News/Cannara+raises+Curaleaf+supply+deal+value+to+C%2434+million/27145977.html <p>Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF) has amended its international supply agreement with Curaleaf International Limited, raising the potential aggregate contract value to approximately C$34 million over two years, up from C$21 million under the original agreement announced July 14, 2026.</p> <p>The amended deal is based on committed supply volumes and the terms and conditions of the agreement. Cannabis flower supplied under the agreement will be dried and processed under EU-GMP conditions at Curaleaf's EU-GMP certified facility in Canada before distribution into international medical markets.</p> <p>Cannara's Chief Operating Officer Niko Sosiak noted that 15 of the company's 24 grow rooms at http://www.streetinsider.com/Corporate+News/Cannara+raises+Curaleaf+supply+deal+value+to+C%2434+million/27145977.html Mon, 05 Oct 2026 08:01:45 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Press+Releases/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html <p align="justify">MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=LZhi8KnegF0w0N6bVUg6YFaM9NQhImCieEhusKJMyVE6ws6aQ-KrLjDtw6KXbydpbEgEESSWL_UekHZLS82ksWe1hTWd7w8RKiiXXFzS2eA=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PltFe73YHeVxHulg481wY7eNvqolAesLwmKPp-BWdloA-xlTPQ66aYDoSdGhzRCtNQUvDm37z_9R9-dsQReuqWz19koqHQG428DXPQP7eSM=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EF9RekxS_tkECAjsocovkRukblDhmQt1CTDaY6PyiE1dXKQKSWF-aJ0oxe4jlddZ9KAJz_oMzvgKR8pTAz__zOfgdKgZnBj0VsgmQDVpvSGhvLHc_fP_CyJzB0D8tEn4" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=RuJaNvHyOB8oDnVKwdFhLspUhkrbGeBixcl-JKf9__hHwcM1sj8G_VenWKpHufYpVzsopgk7yJqScWM8-ARe2ykpofHK4ylLaZAiQUizLmZ75aN44G82-xGbLFb0ch0e" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., is pleased to announce an expansion of its long-term international supply agreement (the “Agreement”) with Curaleaf International Limited (“Curaleaf”), previously announced on July 14, 2026. If fully realized, the amended Agreement has a potential aggregate contract value http://www.streetinsider.com/Press+Releases/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html Mon, 05 Oct 2026 08:00:00 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html <p align="justify">MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=LZhi8KnegF0w0N6bVUg6YFaM9NQhImCieEhusKJMyVE6ws6aQ-KrLjDtw6KXbydpbEgEESSWL_UekHZLS82ksWe1hTWd7w8RKiiXXFzS2eA=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PltFe73YHeVxHulg481wY7eNvqolAesLwmKPp-BWdloA-xlTPQ66aYDoSdGhzRCtNQUvDm37z_9R9-dsQReuqWz19koqHQG428DXPQP7eSM=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EF9RekxS_tkECAjsocovkRukblDhmQt1CTDaY6PyiE1dXKQKSWF-aJ0oxe4jlddZ9KAJz_oMzvgKR8pTAz__zOfgdKgZnBj0VsgmQDVpvSGhvLHc_fP_CyJzB0D8tEn4" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=RuJaNvHyOB8oDnVKwdFhLspUhkrbGeBixcl-JKf9__hHwcM1sj8G_VenWKpHufYpVzsopgk7yJqScWM8-ARe2ykpofHK4ylLaZAiQUizLmZ75aN44G82-xGbLFb0ch0e" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., is pleased to announce an expansion of its long-term international supply agreement (the “Agreement”) with Curaleaf International Limited (“Curaleaf”), previously announced on July 14, 2026. If fully realized, the amended Agreement has a potential aggregate contract value http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html Mon, 05 Oct 2026 08:00:00 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Press+Releases/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html <p align="justify">MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=LZhi8KnegF0w0N6bVUg6YFaM9NQhImCieEhusKJMyVE6ws6aQ-KrLjDtw6KXbydpbEgEESSWL_UekHZLS82ksWe1hTWd7w8RKiiXXFzS2eA=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PltFe73YHeVxHulg481wY7eNvqolAesLwmKPp-BWdloA-xlTPQ66aYDoSdGhzRCtNQUvDm37z_9R9-dsQReuqWz19koqHQG428DXPQP7eSM=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EF9RekxS_tkECAjsocovkRukblDhmQt1CTDaY6PyiE1dXKQKSWF-aJ0oxe4jlddZ9KAJz_oMzvgKR8pTAz__zOfgdKgZnBj0VsgmQDVpvSGhvLHc_fP_CyJzB0D8tEn4" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=RuJaNvHyOB8oDnVKwdFhLspUhkrbGeBixcl-JKf9__hHwcM1sj8G_VenWKpHufYpVzsopgk7yJqScWM8-ARe2ykpofHK4ylLaZAiQUizLmZ75aN44G82-xGbLFb0ch0e" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., is pleased to announce an expansion of its long-term international supply agreement (the “Agreement”) with Curaleaf International Limited (“Curaleaf”), previously announced on July 14, 2026. If fully realized, the amended Agreement has a potential aggregate contract value http://www.streetinsider.com/Press+Releases/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html Mon, 05 Oct 2026 08:00:00 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html <p align="justify">MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=LZhi8KnegF0w0N6bVUg6YFaM9NQhImCieEhusKJMyVE6ws6aQ-KrLjDtw6KXbydpbEgEESSWL_UekHZLS82ksWe1hTWd7w8RKiiXXFzS2eA=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PltFe73YHeVxHulg481wY7eNvqolAesLwmKPp-BWdloA-xlTPQ66aYDoSdGhzRCtNQUvDm37z_9R9-dsQReuqWz19koqHQG428DXPQP7eSM=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EF9RekxS_tkECAjsocovkRukblDhmQt1CTDaY6PyiE1dXKQKSWF-aJ0oxe4jlddZ9KAJz_oMzvgKR8pTAz__zOfgdKgZnBj0VsgmQDVpvSGhvLHc_fP_CyJzB0D8tEn4" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=RuJaNvHyOB8oDnVKwdFhLspUhkrbGeBixcl-JKf9__hHwcM1sj8G_VenWKpHufYpVzsopgk7yJqScWM8-ARe2ykpofHK4ylLaZAiQUizLmZ75aN44G82-xGbLFb0ch0e" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., is pleased to announce an expansion of its long-term international supply agreement (the “Agreement”) with Curaleaf International Limited (“Curaleaf”), previously announced on July 14, 2026. If fully realized, the amended Agreement has a potential aggregate contract value http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html Mon, 05 Oct 2026 08:00:00 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Press+Releases/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html <p align="justify">MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=LZhi8KnegF0w0N6bVUg6YFaM9NQhImCieEhusKJMyVE6ws6aQ-KrLjDtw6KXbydpbEgEESSWL_UekHZLS82ksWe1hTWd7w8RKiiXXFzS2eA=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PltFe73YHeVxHulg481wY7eNvqolAesLwmKPp-BWdloA-xlTPQ66aYDoSdGhzRCtNQUvDm37z_9R9-dsQReuqWz19koqHQG428DXPQP7eSM=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EF9RekxS_tkECAjsocovkRukblDhmQt1CTDaY6PyiE1dXKQKSWF-aJ0oxe4jlddZ9KAJz_oMzvgKR8pTAz__zOfgdKgZnBj0VsgmQDVpvSGhvLHc_fP_CyJzB0D8tEn4" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=RuJaNvHyOB8oDnVKwdFhLspUhkrbGeBixcl-JKf9__hHwcM1sj8G_VenWKpHufYpVzsopgk7yJqScWM8-ARe2ykpofHK4ylLaZAiQUizLmZ75aN44G82-xGbLFb0ch0e" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., is pleased to announce an expansion of its long-term international supply agreement (the “Agreement”) with Curaleaf International Limited (“Curaleaf”), previously announced on July 14, 2026. If fully realized, the amended Agreement has a potential aggregate contract value http://www.streetinsider.com/Press+Releases/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html Mon, 05 Oct 2026 08:00:00 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html <p align="justify">MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=LZhi8KnegF0w0N6bVUg6YFaM9NQhImCieEhusKJMyVE6ws6aQ-KrLjDtw6KXbydpbEgEESSWL_UekHZLS82ksWe1hTWd7w8RKiiXXFzS2eA=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PltFe73YHeVxHulg481wY7eNvqolAesLwmKPp-BWdloA-xlTPQ66aYDoSdGhzRCtNQUvDm37z_9R9-dsQReuqWz19koqHQG428DXPQP7eSM=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EF9RekxS_tkECAjsocovkRukblDhmQt1CTDaY6PyiE1dXKQKSWF-aJ0oxe4jlddZ9KAJz_oMzvgKR8pTAz__zOfgdKgZnBj0VsgmQDVpvSGhvLHc_fP_CyJzB0D8tEn4" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=RuJaNvHyOB8oDnVKwdFhLspUhkrbGeBixcl-JKf9__hHwcM1sj8G_VenWKpHufYpVzsopgk7yJqScWM8-ARe2ykpofHK4ylLaZAiQUizLmZ75aN44G82-xGbLFb0ch0e" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., is pleased to announce an expansion of its long-term international supply agreement (the “Agreement”) with Curaleaf International Limited (“Curaleaf”), previously announced on July 14, 2026. If fully realized, the amended Agreement has a potential aggregate contract value http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html Mon, 05 Oct 2026 08:00:00 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Press+Releases/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html <p align="justify">MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=LZhi8KnegF0w0N6bVUg6YFaM9NQhImCieEhusKJMyVE6ws6aQ-KrLjDtw6KXbydpbEgEESSWL_UekHZLS82ksWe1hTWd7w8RKiiXXFzS2eA=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PltFe73YHeVxHulg481wY7eNvqolAesLwmKPp-BWdloA-xlTPQ66aYDoSdGhzRCtNQUvDm37z_9R9-dsQReuqWz19koqHQG428DXPQP7eSM=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EF9RekxS_tkECAjsocovkRukblDhmQt1CTDaY6PyiE1dXKQKSWF-aJ0oxe4jlddZ9KAJz_oMzvgKR8pTAz__zOfgdKgZnBj0VsgmQDVpvSGhvLHc_fP_CyJzB0D8tEn4" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=RuJaNvHyOB8oDnVKwdFhLspUhkrbGeBixcl-JKf9__hHwcM1sj8G_VenWKpHufYpVzsopgk7yJqScWM8-ARe2ykpofHK4ylLaZAiQUizLmZ75aN44G82-xGbLFb0ch0e" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., is pleased to announce an expansion of its long-term international supply agreement (the “Agreement”) with Curaleaf International Limited (“Curaleaf”), previously announced on July 14, 2026. If fully realized, the amended Agreement has a potential aggregate contract value http://www.streetinsider.com/Press+Releases/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html Mon, 05 Oct 2026 08:00:00 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html <p align="justify">MONTREAL, Oct. 05, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=LZhi8KnegF0w0N6bVUg6YFaM9NQhImCieEhusKJMyVE6ws6aQ-KrLjDtw6KXbydpbEgEESSWL_UekHZLS82ksWe1hTWd7w8RKiiXXFzS2eA=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PltFe73YHeVxHulg481wY7eNvqolAesLwmKPp-BWdloA-xlTPQ66aYDoSdGhzRCtNQUvDm37z_9R9-dsQReuqWz19koqHQG428DXPQP7eSM=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=EF9RekxS_tkECAjsocovkRukblDhmQt1CTDaY6PyiE1dXKQKSWF-aJ0oxe4jlddZ9KAJz_oMzvgKR8pTAz__zOfgdKgZnBj0VsgmQDVpvSGhvLHc_fP_CyJzB0D8tEn4" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=RuJaNvHyOB8oDnVKwdFhLspUhkrbGeBixcl-JKf9__hHwcM1sj8G_VenWKpHufYpVzsopgk7yJqScWM8-ARe2ykpofHK4ylLaZAiQUizLmZ75aN44G82-xGbLFb0ch0e" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., is pleased to announce an expansion of its long-term international supply agreement (the “Agreement”) with Curaleaf International Limited (“Curaleaf”), previously announced on July 14, 2026. If fully realized, the amended Agreement has a potential aggregate contract value http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+International+Supply+Agreement+with+Curaleaf/27145975.html Mon, 05 Oct 2026 08:00:00 -0400 CURA CURLF LOVE LOVFF http://www.streetinsider.com/Corporate+News/Cannara+secures+%2480M+syndicated+credit+facility+with+BMO+and+TD+Bank/27045443.html <p>Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF, FRA: 8CB0) has entered into an amended and restated syndicated credit agreement with Bank of Montreal and The Toronto-Dominion Bank, expanding its total committed borrowing capacity to $80 million, up from approximately $50 million previously accessible.</p> <p>The restated facility, entered into by Cannara's operating subsidiary Cannara Biotech (OPS) Inc., consists of a $40 million term loan and a $40 million revolving credit facility. The revolving capacity was increased from $10 million. Both facilities mature on December 31, 2029, extending the debt maturity by two years from the prior date of December 31, 2027.</p> <p>Bank of http://www.streetinsider.com/Corporate+News/Cannara+secures+%2480M+syndicated+credit+facility+with+BMO+and+TD+Bank/27045443.html Thu, 10 Sep 2026 08:00:42 -0400 LOVE LOVFF http://www.streetinsider.com/Corporate+News/Cannara+secures+%2480M+syndicated+credit+facility+with+BMO+and+TD+Bank/27045443.html <p>Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF, FRA: 8CB0) has entered into an amended and restated syndicated credit agreement with Bank of Montreal and The Toronto-Dominion Bank, expanding its total committed borrowing capacity to $80 million, up from approximately $50 million previously accessible.</p> <p>The restated facility, entered into by Cannara's operating subsidiary Cannara Biotech (OPS) Inc., consists of a $40 million term loan and a $40 million revolving credit facility. The revolving capacity was increased from $10 million. Both facilities mature on December 31, 2029, extending the debt maturity by two years from the prior date of December 31, 2027.</p> <p>Bank of http://www.streetinsider.com/Corporate+News/Cannara+secures+%2480M+syndicated+credit+facility+with+BMO+and+TD+Bank/27045443.html Thu, 10 Sep 2026 08:00:42 -0400 LOVE LOVFF http://www.streetinsider.com/Press+Releases/Cannara+Expands+Financing+to+an+%2480+Million+Syndicated+Credit+Facility+with+BMO+and+TD+Bank%2C+Further+Strengthening+Its+Financial+Foundation+for+Continued+Growth/27045399.html <p align="justify">MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jrPmP2OyzCzGq95yAJ4gJQkhDxheuA1gO6J1R8rNcf2W4awgOynWzUVkHtE8XpqkcgVsculeGbiP68qWW_KBTB_qulyl8DyqE__ad_8HG-A=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Drh8ch8q5qxn-NEbrOJKkSq93AjD-BW_OatuqwP-QtDqrY7O8dfW5TpAi1vrvz3ZtyRkP5zXnpD5yNsLDDDL9_j_pLDXT_5lRacy3lQ_HmE=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=oTkHsok2SUZ04yPaJjUge4kpbSYbLVD6ADauh6A0f4y43iZDFYzhW8bqe6oRAWVtmItbj7Wz_tUvv7JSq-2mrGRha4LPRno9yJf97eMPsI_TtOnBKAF0WmUvBp7gO8wp" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=HVDFHNLaQiLegDOleFBr2AHn4uG1RpQptse7eL90LR3QWhzhJL-1tZQ1Ojd8RPr_lN0YZaj4d6TabOE4PJdGPhA1X8J3PYGVMPnWAIXlRMUlnpPNnujl-W48gqYSJ9Nx" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that its operating subsidiary, Cannara Biotech (OPS) Inc., has entered into an amended and restated syndicated credit agreement (the &quot;<strong>Restated Credit Facility</strong>&quot;) with Bank of Montreal (&quot;<strong>BMO</strong>&quot;) and The Toronto-Dominion Bank (&quot;<strong>TD</strong>&quot;). The Restated Credit http://www.streetinsider.com/Press+Releases/Cannara+Expands+Financing+to+an+%2480+Million+Syndicated+Credit+Facility+with+BMO+and+TD+Bank%2C+Further+Strengthening+Its+Financial+Foundation+for+Continued+Growth/27045399.html Thu, 10 Sep 2026 08:00:00 -0400 LOVE LOVFF http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+Financing+to+an+%2480+Million+Syndicated+Credit+Facility+with+BMO+and+TD+Bank%2C+Further+Strengthening+Its+Financial+Foundation+for+Continued+Growth/27045399.html <p align="justify">MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jrPmP2OyzCzGq95yAJ4gJQkhDxheuA1gO6J1R8rNcf2W4awgOynWzUVkHtE8XpqkcgVsculeGbiP68qWW_KBTB_qulyl8DyqE__ad_8HG-A=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Drh8ch8q5qxn-NEbrOJKkSq93AjD-BW_OatuqwP-QtDqrY7O8dfW5TpAi1vrvz3ZtyRkP5zXnpD5yNsLDDDL9_j_pLDXT_5lRacy3lQ_HmE=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=oTkHsok2SUZ04yPaJjUge4kpbSYbLVD6ADauh6A0f4y43iZDFYzhW8bqe6oRAWVtmItbj7Wz_tUvv7JSq-2mrGRha4LPRno9yJf97eMPsI_TtOnBKAF0WmUvBp7gO8wp" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=HVDFHNLaQiLegDOleFBr2AHn4uG1RpQptse7eL90LR3QWhzhJL-1tZQ1Ojd8RPr_lN0YZaj4d6TabOE4PJdGPhA1X8J3PYGVMPnWAIXlRMUlnpPNnujl-W48gqYSJ9Nx" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that its operating subsidiary, Cannara Biotech (OPS) Inc., has entered into an amended and restated syndicated credit agreement (the &quot;<strong>Restated Credit Facility</strong>&quot;) with Bank of Montreal (&quot;<strong>BMO</strong>&quot;) and The Toronto-Dominion Bank (&quot;<strong>TD</strong>&quot;). The Restated Credit http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+Financing+to+an+%2480+Million+Syndicated+Credit+Facility+with+BMO+and+TD+Bank%2C+Further+Strengthening+Its+Financial+Foundation+for+Continued+Growth/27045399.html Thu, 10 Sep 2026 08:00:00 -0400 LOVE LOVFF http://www.streetinsider.com/Press+Releases/Cannara+Expands+Financing+to+an+%2480+Million+Syndicated+Credit+Facility+with+BMO+and+TD+Bank%2C+Further+Strengthening+Its+Financial+Foundation+for+Continued+Growth/27045399.html <p align="justify">MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jrPmP2OyzCzGq95yAJ4gJQkhDxheuA1gO6J1R8rNcf2W4awgOynWzUVkHtE8XpqkcgVsculeGbiP68qWW_KBTB_qulyl8DyqE__ad_8HG-A=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Drh8ch8q5qxn-NEbrOJKkSq93AjD-BW_OatuqwP-QtDqrY7O8dfW5TpAi1vrvz3ZtyRkP5zXnpD5yNsLDDDL9_j_pLDXT_5lRacy3lQ_HmE=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=oTkHsok2SUZ04yPaJjUge4kpbSYbLVD6ADauh6A0f4y43iZDFYzhW8bqe6oRAWVtmItbj7Wz_tUvv7JSq-2mrGRha4LPRno9yJf97eMPsI_TtOnBKAF0WmUvBp7gO8wp" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=HVDFHNLaQiLegDOleFBr2AHn4uG1RpQptse7eL90LR3QWhzhJL-1tZQ1Ojd8RPr_lN0YZaj4d6TabOE4PJdGPhA1X8J3PYGVMPnWAIXlRMUlnpPNnujl-W48gqYSJ9Nx" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that its operating subsidiary, Cannara Biotech (OPS) Inc., has entered into an amended and restated syndicated credit agreement (the &quot;<strong>Restated Credit Facility</strong>&quot;) with Bank of Montreal (&quot;<strong>BMO</strong>&quot;) and The Toronto-Dominion Bank (&quot;<strong>TD</strong>&quot;). The Restated Credit http://www.streetinsider.com/Press+Releases/Cannara+Expands+Financing+to+an+%2480+Million+Syndicated+Credit+Facility+with+BMO+and+TD+Bank%2C+Further+Strengthening+Its+Financial+Foundation+for+Continued+Growth/27045399.html Thu, 10 Sep 2026 08:00:00 -0400 LOVE LOVFF http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+Financing+to+an+%2480+Million+Syndicated+Credit+Facility+with+BMO+and+TD+Bank%2C+Further+Strengthening+Its+Financial+Foundation+for+Continued+Growth/27045399.html <p align="justify">MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jrPmP2OyzCzGq95yAJ4gJQkhDxheuA1gO6J1R8rNcf2W4awgOynWzUVkHtE8XpqkcgVsculeGbiP68qWW_KBTB_qulyl8DyqE__ad_8HG-A=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Drh8ch8q5qxn-NEbrOJKkSq93AjD-BW_OatuqwP-QtDqrY7O8dfW5TpAi1vrvz3ZtyRkP5zXnpD5yNsLDDDL9_j_pLDXT_5lRacy3lQ_HmE=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=oTkHsok2SUZ04yPaJjUge4kpbSYbLVD6ADauh6A0f4y43iZDFYzhW8bqe6oRAWVtmItbj7Wz_tUvv7JSq-2mrGRha4LPRno9yJf97eMPsI_TtOnBKAF0WmUvBp7gO8wp" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=HVDFHNLaQiLegDOleFBr2AHn4uG1RpQptse7eL90LR3QWhzhJL-1tZQ1Ojd8RPr_lN0YZaj4d6TabOE4PJdGPhA1X8J3PYGVMPnWAIXlRMUlnpPNnujl-W48gqYSJ9Nx" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that its operating subsidiary, Cannara Biotech (OPS) Inc., has entered into an amended and restated syndicated credit agreement (the &quot;<strong>Restated Credit Facility</strong>&quot;) with Bank of Montreal (&quot;<strong>BMO</strong>&quot;) and The Toronto-Dominion Bank (&quot;<strong>TD</strong>&quot;). The Restated Credit http://www.streetinsider.com/Globe+Newswire/Cannara+Expands+Financing+to+an+%2480+Million+Syndicated+Credit+Facility+with+BMO+and+TD+Bank%2C+Further+Strengthening+Its+Financial+Foundation+for+Continued+Growth/27045399.html Thu, 10 Sep 2026 08:00:00 -0400 LOVE LOVFF http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Globe+Newswire/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081 http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html <p align="justify">MONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fGRpz3BfkwGsq0uNOcvIqGpc43QDHe90IEvlPGGko5Nc1FgPO23qUjMD_6af5RmKbexIBjs1AtWZhUTG8TciyX89GGdCHmVCjSfAMptFmIY=" rel="nofollow" target="_blank">Cannara Biotech Inc.</a> (“<strong>Cannara</strong>”, the “<strong>Company</strong>”, “<strong>us</strong>” or “<strong>we</strong>”) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=ou3Eye31cVdla6Lpp113fT-_xkEXmm0GFdaFyHvJpa5Uwciylxt7RNJGZ8ULxcEHftxhMycVgWQOFfvUc1OofQvY0QcMc4yvPEkHE9RI5ts=" rel="nofollow" target="_blank">TSX: LOVE</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=Muh7FlkabjwJEce113RU45TvfX_b__NaTc322hzNrsW8rpSgkCFymgsIExJDP7ZQ_-N_kATBqG2znpXCxcGtp9RZktBP1xoOEg-V9FVyf9_5lp2lBcEddv5-MAsO9RVQ" rel="nofollow" target="_blank">OTCQX: LOVFF</a>) (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=PczigRl-bOW34ELYCXLWY50z0EUl-2LlAPDhyResQywGBOOV4b224-ik0YjQvq6ZO5zfM66eJT62pPjzA4jX3eD341gRkfu_ppR-K38_TpwO-aefAD6vPHm35qEfJnYZ" rel="nofollow" target="_blank">FRA: 8CB0</a>), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., announced today that, in connection with its previously announced normal course issuer bid (“<strong>NCIB</strong>”) to purchase up to 1,975,642 of its common shares (“<strong>Shares</strong>”) during the twelve-month period commencing August 4, 2026, and ending August 3, 2027, http://www.streetinsider.com/Press+Releases/Cannara+Establishes+Automatic+Share+Purchase+Plan/26916811.html Thu, 13 Aug 2026 08:00:00 -0400 8CB0 A.12348980 A.36078215 LOVE LOVFF O.01271557 O.02555813 O.41123081